[Skip to Content]
[Skip to Content Landing]
Views 288
Citations 0
Comment & Response
March 14, 2019

Undissected Axilla and Axillary Radiotherapy

Author Affiliations
  • 1Royal Derby Hospital, Derby, United Kingdom
  • 2The Royal Melbourne and Royal Women’s Hospital, Parkville, Australia
  • 3Baylor College of Medicine, Houston, Texas
JAMA Oncol. 2019;5(5):741-742. doi:10.1001/jamaoncol.2019.0031

To the Editor We read with interest the study of surgeon attitudes toward the omission of axillary lymph node dissection (ALND) in early breast cancer.1 A previous survey of 849 members of the American Society of Breast Surgeons suggested that “respondents have embraced [the ACOSOG] Z0011 [trial] and omit ALND in patients with 1 or 2 positive nodes.”2 In contrast, we now learn that only higher-volume breast cancer surgeons with multidisciplinary interactions are less likely to propose ALND for patients with limited disease in the sentinel node, whereas low-volume surgeons should be targeted for remedial education.1

×